Biocompatibility of heparin-coated extracorporeal bypass circuits: A randomized, masked clinical trial
- 1 August 1996
- journal article
- clinical trial
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 112 (2) , 472-483
- https://doi.org/10.1016/s0022-5223(96)70275-1
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Heparin-coated cardiopulmonary bypass circuits: Hemostatic alterations and postoperative blood lossThe Annals of Thoracic Surgery, 1994
- Risk and benefit of low systemic heparinization during open heart operationsThe Annals of Thoracic Surgery, 1994
- Heparin coating reduces blood cell adhesion to arterial filters during coronary bypass: A clinical studyThe Annals of Thoracic Surgery, 1993
- Inflammatory response to cardiopulmonary bypassThe Annals of Thoracic Surgery, 1993
- Release of vasoactive substances during cardiopulmonary bypassThe Annals of Thoracic Surgery, 1992
- Stratification of Morbidity and Mortality Outcome by Preoperative Risk Factors in Coronary Artery Bypass PatientsJAMA, 1992
- Clinical experience with heparin-coated cardiopulmonary bypass circuitsPerfusion, 1991
- Biocompatibility of extracorporeal circulationThe Journal of Thoracic and Cardiovascular Surgery, 1991
- In vivo biocompatibility studies. V. In vivo leukocyte interactions with biomerJournal of Biomedical Materials Research, 1984
- A New Non-Thrombogenic Surface Prepared by Selective Covalent Binding of Heparin Via a Modified Reducing Terminal ResidueBiomaterials, Medical Devices, and Artificial Organs, 1983